查詢結果分析
相關文獻
- Sorafenib in Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation
- A Primary Hepatic Lymphoma Mimicking Delayed Metastasis of Renal Cell Carcinoma
- Sinonasal Metastatic Tumors in Taiwan
- Metastatic Malignancy in the Submadibular Gland--A Case Report of Renal Cell Carcinoma Metastasis to the Submandibular Gland
- 腎臟癌併腹主動脈旁淋巴轉移病人接受身體立體定位放射治療之照護--病例報告
- Bacillus macerans之環狀糊精葡萄糖苷基轉移酶基因在枯草桿菌中的胞外表現
- 以側頸囊腫表徵之轉移性乳頭狀甲狀腺癌--二例報告
- Metastatic Hepatocellular Carcinoma Presenting as Hemocholecyst with Perforation: A Case Report
- 利用相間轉移觸媒合成對-羥基苯甲酸丁酯之研究
- 輸送眼藥用之原位成膠PAA、Gelrite及PAA/Gelrite系統流變行為之探討
頁籤選單縮合
| 題 名 | Sorafenib in Metastatic Renal Cell Carcinoma With Sarcomatoid Differentiation=已蕾莎瓦(Sorafenib)治療轉移性腎臟癌合併類肉瘤分化 |
|---|---|
| 作 者 | Lekili, Murat; Muezzinoglu, Talha; Nese, Nalan; Temeltas, Gokhan; | 書刊名 | Journal of the Chinese Medical Association |
| 卷 期 | 73:5 2010.05[民99.05] |
| 頁 次 | 頁262-264+CA46 |
| 關鍵詞 | 轉移; 腎臟癌; 類肉瘤分化; 蕾莎瓦; Sorafenib; Metastasis; Renal cell cancer; Sarcomatoid differentiation; |
| 語 文 | 英文(English) |
| 英文摘要 | Targeted therapy in the management of metastatic renal cell cancer has been recently introduced to urology practice. The drugs used for management are used in a very limited number of patients and only for clear cell histology. We present a case where we administered sorafenib, a multikinase inhibitor of tumor-cell proliferation and angiogenesis, to a patient with metastatic renal cell carcinoma of clear cell histology. We found that our results were different from those of previously reported studies, because sarcomatoid differentiation was evident in a histological examination of this case. There was an excellent response to sorafenib. This case report might provide evidence that antiangiogenic agents may be active in any histological type of renal cell carcinoma. However, there are no available data to demonstrate the duration of response and survival benefit. |
本系統中英文摘要資訊取自各篇刊載內容。